Skip to content

ACRSACLARIS THERAPEUTICS INC

CUSIP 00461U105 · common stock

2 tracked investors held ACLARIS THERAPEUTICS INC (ACRS) at the end of Q3 2026, worth $67M in total. The largest holder was RA Capital Management, with 0.7% of its portfolio. Adar1 Capital Management opened a new position this quarter.

Holders · Q3 2026
2
New holders
1
Value held
$67M
Quarter-end price (est.)
$5.26

Investors holding ACRS · Q3 2026

InvestorWeightSharesValueChange
RA Capital Management
RA Capital Management, L.P.
0.67%12,723,026$66.9MHOLD
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.00%22,000$115.7KNEW

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026210$67M$5.26
Q2 2026101$67.3M$5.29
Q1 2026210$26M$3.75
Q4 2025100$1.8M$3.01